Cardiology board review by examination
Board-style practice examinations for cardiovascular disease, echocardiography, nuclear cardiology, and cardiac CT certification, with library reading for each.
Practice examinations
Each examination draws from a bank of board-style questions. In study mode the explanation follows each answer. In timed mode the full set is scored at the end.
For cardiovascular disease certification
Cardiovascular Medicine
Coronary disease, heart failure, arrhythmias, valvular disease, and vascular disease, with guideline-based explanations.
400 questions
For the ASCeXAM
Adult Echocardiography
Doppler and instrumentation, valvular hemodynamics, chamber quantification, diastolic function, adult congenital heart disease, cardiac masses, and pericardial physiology.
80 questions
For the CBNC examination
Nuclear Cardiology
SPECT and PET perfusion, radiopharmaceuticals, instrumentation and processing, attenuation artifacts, viability, risk stratification, and radiation safety.
80 questions
For the CBCCT examination
Cardiac CT
Acquisition and contrast protocols, artifacts, plaque and stenosis assessment, CAD-RADS 2.0, CT-derived fractional flow reserve, calcium scoring, and structural and congenital CT.
80 questions
Reading for each examination
These library pages address topics within the content areas of each examination.
Cardiovascular Medicine
- ACE inhibitors, angiotensin receptor blockers, and sacubitril/valsartan
- Acute and recurrent pericarditis
- Acute aortic syndromes: dissection, intramural hematoma, and penetrating ulcer
- Acute decompensated heart failure and acute pulmonary edema
- Adult cardiac arrest and advanced cardiovascular life support
- Antianginal drugs: nitrates, ranolazine, and others
- Antiarrhythmic drugs
- Anticoagulant bleeding, reversal, and periprocedural management
- Antithrombotic therapy in atrial fibrillation with PCI
- Aortic stenosis
- Atrial fibrillation
- Atrial septal defect and patent foramen ovale
- Beta-blockers in cardiovascular disease
- Bradycardia and atrioventricular block
- Calcium channel blockers
- Cardiac amyloidosis
- Cardiac intensive care: ventilation, sepsis, and organ support
- Cardiogenic shock
- Cardiovascular drug interactions, renal dosing, and dosing in older adults
- Cardiovascular risk assessment for primary prevention
- Cardiovascular toxicology: poisoning, overdose and anaphylaxis
- Chronic coronary disease and stable angina
- Colchicine and anti-inflammatory therapy in cardiovascular disease
- Constrictive pericarditis and its distinction from restrictive cardiomyopathy
- Coronary CT angiography and calcium scoring
- Digoxin: rate control, heart failure, and toxicity
- Direct oral anticoagulants: apixaban, rivaroxaban, dabigatran, and edoxaban
- Diuretics in heart failure and hypertension
- Drug-induced cardiovascular disease
- Dual antiplatelet therapy: duration, de-escalation, and bleeding risk
- Dyslipidemia: LDL cholesterol lowering, triglycerides, and lipoprotein(a)
- Electrical storm and incessant ventricular tachycardia
- Fibrinolytic therapy: agents, dosing, indications, and contraindications
- GLP-1 receptor agonists and tirzepatide in cardiovascular disease
- Heart failure with preserved ejection fraction and diastolic dysfunction
- Heart failure with reduced ejection fraction
- Hypertension in adults
- Hypertensive emergency and severe hypertension
- Hypertrophic cardiomyopathy
- Infective endocarditis
- Ivabradine, vericiguat, and hydralazine-isosorbide dinitrate in heart failure
- Long QT syndrome and drug-induced QT prolongation
- Lower extremity peripheral artery disease
- Mineralocorticoid receptor antagonists: spironolactone, eplerenone, and finerenone
- Mitral regurgitation
- Myocardial perfusion imaging with SPECT and PET
- Non-ST-elevation acute coronary syndrome
- Nonstatin LDL-lowering therapies: ezetimibe, PCSK9 inhibitors, inclisiran, and bempedoic acid
- Parenteral anticoagulants and heparin-induced thrombocytopenia
- Pericardial effusion and cardiac tamponade
- Post-cardiac arrest care
- Prosthetic heart valves
- Pulmonary arterial hypertension therapy
- Pulmonary embolism
- Pulmonary hypertension
- Right heart catheterization and hemodynamic calculations
- SGLT2 inhibitors in heart failure, kidney disease, and diabetes
- ST-elevation myocardial infarction
- Statins: pharmacology, intensity, intolerance, and interactions
- Transthoracic echocardiography: standard views, chamber quantification, and normal values
- Vasopressors and inotropes
- Ventricular tachycardia and sudden cardiac death
- Warfarin: dosing, INR management, and reversal
Adult Echocardiography
- Acute and recurrent pericarditis
- Aortic stenosis
- Atrial septal defect and patent foramen ovale
- Cardiac amyloidosis
- Constrictive pericarditis and its distinction from restrictive cardiomyopathy
- Heart failure with preserved ejection fraction and diastolic dysfunction
- Hypertrophic cardiomyopathy
- Infective endocarditis
- Mitral regurgitation
- Prosthetic heart valves
- Pulmonary hypertension
- Right heart catheterization and hemodynamic calculations
- Transthoracic echocardiography: standard views, chamber quantification, and normal values
Nuclear Cardiology
Cardiac CT
- Acute aortic syndromes: dissection, intramural hematoma, and penetrating ulcer
- Aortic stenosis
- Atrial septal defect and patent foramen ovale
- Cardiovascular risk assessment for primary prevention
- Chronic coronary disease and stable angina
- Constrictive pericarditis and its distinction from restrictive cardiomyopathy
- Coronary CT angiography and calcium scoring
- Mitral regurgitation
- Prosthetic heart valves
- Pulmonary embolism